Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

GITRL RNA-transfected autologous dendritic cell vaccine

An autologous dendritic cell (DC) cancer vaccine with potential immunostimulatory activity. GITRL RNA-transfected autologous DC vaccine is prepared by transfecting DCs with RNAs encoding tumor necrosis factor (ligand) superfamily, member 18 (TNFSF18 or GlTRL); expression of GlTRL results in modulating T lymphocyte survival in peripheral tissues. Co-vaccination of this vaccine with melanoma antigen specific vaccine may eliminate the adverse effects associated with systemic administration of immune modulators, while also enhancing vaccine-induced immune responses.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:GITRL RNA-transfected autologous DC
GITRL RNA-transfected autologous dendritic cells
Abbreviation:GITRL RNA DC
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search